VANDA PHARMA (VM4.SG)
VANDA PHARMA (VM4.SG) operates in Diversified Metals & Mining.
VANDA PHARMA (VM4.SG) (VM4) - Total Assets
Latest total assets as of September 2024: €645.12 Million EUR
Based on the latest financial reports, VANDA PHARMA (VM4.SG) (VM4) holds total assets worth €645.12 Million EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
VANDA PHARMA (VM4.SG) - Total Assets Trend (2016–2023)
This chart illustrates how VANDA PHARMA (VM4.SG)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
VANDA PHARMA (VM4.SG) - Asset Composition Analysis
Current Asset Composition (December 2023)
VANDA PHARMA (VM4.SG)'s total assets of €645.12 Million consist of 66.8% current assets and 33.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 21.0% |
| Accounts Receivable | €34.16 Million | 5.3% |
| Inventory | €1.36 Million | 0.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €121.37 Million | 18.7% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how VANDA PHARMA (VM4.SG)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: VANDA PHARMA (VM4.SG)'s current assets represent 66.8% of total assets in 2023, a decrease from 82.8% in 2016.
- Cash Position: Cash and equivalents constituted 21.0% of total assets in 2023, up from 19.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 13.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 18.7% of total assets.
VANDA PHARMA (VM4.SG) Competitors by Total Assets
Key competitors of VANDA PHARMA (VM4.SG) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
VANDA PHARMA (VM4.SG) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - VANDA PHARMA (VM4.SG) generates 0.30x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, VANDA PHARMA (VM4.SG) generates $ 0.39 in net profit.
VANDA PHARMA (VM4.SG) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.85 | 6.32 | 5.95 |
| Quick Ratio | 4.84 | 6.31 | 5.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €343.30 Million | € 451.74 Million | € 294.63 Million |
VANDA PHARMA (VM4.SG) - Advanced Valuation Insights
This section examines the relationship between VANDA PHARMA (VM4.SG)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 2.2% |
| Total Assets | €648.44 Million |
| Market Capitalization | $81.90K USD |
Valuation Analysis
Below Book Valuation: The market values VANDA PHARMA (VM4.SG)'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: VANDA PHARMA (VM4.SG)'s assets grew by 2.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for VANDA PHARMA (VM4.SG) (2016–2023)
The table below shows the annual total assets of VANDA PHARMA (VM4.SG) from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €648.44 Million | +2.24% |
| 2022-12-31 | €634.25 Million | +6.81% |
| 2021-12-31 | €593.79 Million | +11.31% |
| 2020-12-31 | €533.46 Million | +10.28% |
| 2019-12-31 | €483.75 Million | +45.65% |
| 2018-12-31 | €332.13 Million | +61.68% |
| 2017-12-31 | €205.43 Million | -2.35% |
| 2016-12-31 | €210.37 Million | -- |